Clinical Decision Support Coalition letter criticizes FDA's stance on CDS

Yesterday the Clinical Decision Support (CDS) Coalition released a comment broadly criticizing the FDA’s recent CDS draft guidance, noting that the draft would expand the scope of FDA regulations, and that it fails to take a risk-based approach, lumping in many low-risk programs already on the market. 

from MobiHealthNews http://ift.tt/2BHA3AN